Combination Drugs Segment to Drive Growth of Chronic Cough Market during 2020-2027
According to our new market research study titled Chronic Cough Market Global Analysis and Forecast by Drug Class, Route of Administration, and Distribution Channel the global chronic cough market is expected to reach US$ 9,854.8 million by 2027 from US$ 5,430.0 million in 2019; it is estimated to grow at a CAGR of 7.8% from 2020 to 2027. The report highlights the trends prevalent in the global chronic cough market, and the drivers and deterrents pertaining to its growth.
Based on drug class, the chronic cough market is segmented into antihistamines, cortico steroids, decongestants,combination drug, antibiotics, acid blockers, and others drug class. The combination drug segment held the largest share of the market in 2019 and the same segment is anticipated to register the highest CAGR in the market during the forecast period. The growth of the market through combination drug segments is estimated to grow due to enhanced sales of combination drugs over the counter and the use of combination drugs targets more symptoms in a single use.
The growth of the market is attributed to the factors such as increase in rising incidences of chronic cough and growing product developments to treat chronic cough. On the other hand, product recall is the major factor likely to restraint the market growth during the forecast period.
Novartis AG; TevaPharmaceutical Industries Ltd; GlaxoSmithKline plc; Bayer AG; Mylan N.V; AmnealPharmaceuticals, Inc; Cipla Inc; Reckitt Benckiser Group plc; SunPharmaceutical Industries Ltd; and Aurobindo Pharma Ltd are some of the prominentplayers operating in the chronic cough market. The market players are focused onorganic strategies to sustain their position in the market. For instance, in October,2019, Aurobindo Pharma received final approval from the United States Food andDrug Administration (USFDA) to manufacture its generic Guaifenesinextended-release tablets in the strengths of 600 mg and 1,200 mg.
Global Chronic Cough Market, By Region, 2019 (%)
Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class); Route of Administration (Oral, Injections, Inhalation, Other and Route of Administration); Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy); and Geography
Chronic Cough Market Size, Share, Analysis & Forecast by 2027
Download Free Sample
The report segments the global chronic cough market as follows:
Global Chronic Cough Market - By Drug Class
- Antihistamines
- Cortico steroids
- Decongestants
- Combination Drug
- Antibiotics
- Acid Blockers
- Other Drug Class
Global Chronic Cough Market - By Route of Administration
- Oral
- Injections
- Nasal
- Other Route of Administration
Global Chronic Cough Market - By Distribution Channel
- Commercial or Private Labs
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global Chronic Cough Market - By Geography
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Asia Pacific (APAC)
- Japan
- China
- India
- Australia
- South Korea
- Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- South and Central America (SCAM)
- Brazil
- Argentina